Skip to main content

Alpine Immune Sciences, Inc.

ALPNDelisted May 20, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001626199

Alpine Immune Sciences, Inc. was delisted on May 20, 2024; its insiders filed their last Form 4 on May 20, 2024; 180 institutions reported holding it in 13F filings for Q1 2024, worth $2.56B in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Alpine Immune Sciences, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of ALPN: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders5870+12
Shares24.0M39.5M+15.4M (+64.3%)
Value$204.4M$284.0M+$79.7M (+39.0%)

New holders (16)

Institutions that held Alpine Immune Sciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to ALPN in Q3 2022
InstitutionSharesValue% of portfolio
Ra Capital Management, L.P.4,356,632$31.4M0.67%
Commodore Capital LP1,325,000$9.54M1.53%
Octagon Capital Advisors LP1,225,000$8.82M1.52%
Sphera Funds Management Ltd.200,000$1.44M0.26%
Affinity Asset Advisors, LLC110,000$792.0K0.37%
Monashee Investment Management LLC100,000$720.0K0.27%
Walleye Capital LLC71,355$514.0K0.01%
Caas Capital Management LP45,354$327.0K0.04%
Jacobs Levy Equity Management, Inc17,753$128.0K0.00%
Price T Rowe Associates Inc12,615$91.0K0.00%
Trexquant Investment LP10,726$77.0K0.00%
Jump Financial, LLC10,013$72.0K0.00%
BIT Capital GmbH6,000$43.2K0.01%
Public Employees Retirement System of Ohio4,879$35.0K0.00%
China Universal Asset Management Co., Ltd.285$2.00K0.00%
Tradewinds Capital Management, LLC15$00.00%

Sold out (4)

Institutions that held Alpine Immune Sciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of ALPN in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Western Standard LLC50,328$428.0K
Susquehanna International Group, LLP14,121$120.0K
Lazard Asset Management LLC4,617$39.0K
UBS Group AG1,200$10.0K